Cited by 32Organ Transplantation Techniques and OutcomesChronic Kidney Disease and DiabetesRenal Transplantation Outcomes and Treatments

Cardiovascular disease outcomes related to early stage renal impairment after liver transplantation

Open access
VanWagner, Lisa B., Montag, Samantha, Zhao, Lihui, Allen, Norrina B., Lloyd-Jones, Donald M., Das, Arighno, Skaro, Anton I., Hohmann, Samuel +2 more·2018·Transplantation

Abstract

BACKGROUND: In the general population, even mild renal disease is associated with increased cardiovascular (CV) complications. Whether this is true in liver transplant recipients (LTR) is unknown. METHODS: This was a retrospective cohort study of 671 LTR (2002-2012) from a large urban tertiary care center and 37 322 LTR using Vizient hospitalization data linked to the United Network for Organ Sharing. The 4-variable Modification of Diet in Renal Disease equation estimated glomerular filtration rate (eGFR). Outcomes were 1-year CV complications (death/hospitalization from myocardial infarction, heart failure, atrial fibrillation, cardiac arrest, pulmonary embolism, or stroke) and mortality. Latent mixture modeling identified trajectories in eGFR in the first liver transplantation (LT) year in the 671 patients. RESULTS: Mean (SD) eGFR was 72.1 (45.7) mL/min per 1.73 m. Six distinct eGFR trajectories were identified in the local cohort (n = 671): qualitatively normal-slow decrease (4% of cohort), normal-rapid decrease (4%), mild-stable (18%), mild-slow decrease (35%), moderate-stable (30%), and severe-stable (9%). In multivariable analyses adjusted for confounders and baseline eGFR, the greatest odds of 1-year CV complications were in the normal-rapid decrease group (odds ratio, 10.6; 95% confidence interval, 3.0-36.9). Among the national cohort, each 5-unit lower eGFR at LT was associated with a 2% and 5% higher hazard of all-cause and CV-mortality, respectively (P < 0.0001), independent of multiple confounders. CONCLUSIONS: Even mild renal disease at the time of LT is a risk factor for posttransplant all-cause and CV mortality. More rapid declines in eGFR soon after LT correlate with risk of adverse CV outcomes, highlighting the need to study whether early renal preservation interventions also reduce CV complications.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/tp.0000000000002175

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Liver transplant recipients with T2D and chronic kidney disease are at the highest risk for cardiovascular events.

    “Cardiovascular complications are the second most common cause of non-hepatic mortality in liver transplant recipients, 512 and those with T2D 513 and chronic kidney disease 514 are at the highest risk for cardiovascular events.”

    From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [514]

    The Discussion (page unavailable) reports that lower kidney function after liver transplantation is associated with higher cardiovascular risk, supporting the CKD portion attributed to citation 514. But the Results identify recipients with a rapid decline from initially normal kidney function—not recipients with CKD generally—as having the greatest odds of cardiovascular complications. T2D is attached to a separate citation and is not judged here. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [28]Wickham H ggplot2: Elegant Graphics for Data Analysis New York Springer-Verlag 2009

Cited by

Sorted by citations

Authors
VanWagner, L. B., Montag, S., Zhao, L., Allen, N. B., Lloyd-Jones, D. M., Das, A., Skaro, A. I., Hohmann, S., Friedewald, J. J., & Levitsky, J.
Affiliations
  • Northwestern University (US)
  • Western University (CA)
Corresponding author
Levitsky, Josh
Venue
Transplantation
Published
2018-07
Volume
102
Issue
7
Pages
1096-1107
ISSN
0041-1337 (ISSN-L)
OpenAlex
W2789778816
Cited by
32
References
50
Citations by year
2026: 2 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 5 · 2021: 6 · 2020: 7 · 2019: 4 · 2018: 2
FWCI
4.94
Type
journal article
Language
en
Open access
Locations
  • Transplantation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (KL2TR001424, UL1TR001422, KL2TR000107)
  • National Institute on Aging (R21AG049385)
  • National Heart, Lung, and Blood Institute (F32HL116151, K23HL136891)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
Keywords
liver transplantation, cardiovascular complications, estimated glomerular filtration rate, post-transplant mortality, cardiovascular mortality, myocardial infarction, heart failure, atrial fibrillation
MeSH terms
Adult, Aged, Cardiovascular Diseases, Creatinine, Female, Glomerular Filtration Rate, Humans, Kidney, Male, Middle Aged, Postoperative Complications, Retrospective Studies, Risk Factors, Severity of Illness Index, Time Factors, Liver Transplantation, Renal Insufficiency, End Stage Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review